Among the recognized subtypes of migraine, migraine with brainstem aura occupies a distinctive position. It is rare enough that most people with migraine will never experience it, and rare enough that many clinicians have limited direct experience with it. It is also alarming enough in its presentation that people who do experience it frequently end up in emergency departments, convinced they are having a stroke. And it carries specific treatment considerations that make it clinically important to recognize correctly.
Previously called basilar-type migraine or basilar artery migraine, the condition was renamed migraine with brainstem aura in the third edition of the International Classification of Headache Disorders to better reflect current understanding of its mechanism. The old terminology implied that the condition was caused by spasm of the basilar artery, a hypothesis that has not been supported by subsequent research. The newer terminology reflects the understanding that the aura symptoms originate from the brainstem.
Migraine with brainstem aura is distinguished from other aura subtypes by the specific neurological symptoms that characterize its aura phase. These symptoms reflect dysfunction in brainstem regions rather than in cortical areas.
The International Headache Society criteria for migraine with brainstem aura require at least two of the following aura symptoms: dysarthria, meaning slurred or poorly articulated speech; vertigo; tinnitus; hypacusis, meaning reduced hearing; diplopia, meaning double vision; ataxia, meaning coordination problems and unsteady gait; and a decreased level of consciousness. These symptoms must not include motor weakness, which would indicate hemiplegic migraine rather than brainstem aura, and must meet the general aura criteria of gradual onset over five or more minutes and resolution within sixty minutes.
The headache that typically follows brainstem aura is usually occipital in location, meaning it affects the back of the head, reflecting the brainstem and posterior circulation origin of the symptoms. The attack as a whole can be severely disabling and frightening.
Migraine with brainstem aura is rare. Prevalence estimates vary but consistently describe it as a small minority of the migraine population. It is more common in women than in men. It most commonly begins in adolescence or early adulthood, and many people who experience it also have attacks of typical migraine with or without aura, making the brainstem aura episodes stand out as different from their usual pattern.
Understanding the specific symptoms of brainstem aura and how they present helps clarify why misdiagnosis with stroke or transient ischemic attack is so common.
Dysarthria in brainstem aura produces slurred, poorly articulated speech. Unlike the aphasia that can accompany typical aura or occur in stroke, dysarthria specifically affects the motor execution of speech rather than language comprehension or word selection.
Vertigo in brainstem aura is typically true rotational vertigo rather than lightheadedness. It can be severe and incapacitating during the aura phase.
Tinnitus and hypacusis reflect dysfunction in auditory processing pathways that pass through the brainstem. Diplopia reflects disruption of the oculomotor pathways that coordinate eye movement, which are controlled by brainstem nuclei.
Ataxia during brainstem aura can produce significant gait unsteadiness that makes walking difficult or unsafe during the aura phase.
Decreased level of consciousness, ranging from mild confusion to syncope, is the most alarming symptom of brainstem aura and is the one most likely to generate emergency medical responses. It occurs in a subset of attacks and reflects the involvement of the reticular activating system, which regulates wakefulness.
The symptoms of migraine with brainstem aura closely resemble those of posterior circulation stroke and transient ischemic attack. The features that help distinguish brainstem aura from posterior circulation stroke include the gradual onset of symptoms over five or more minutes, which contrasts with the abrupt onset typical of stroke. The complete resolution of symptoms within sixty minutes. The subsequent development of headache with migraine features. And the prior history of migraine.
When brainstem aura occurs for the first time without a prior migraine history, the distinction from stroke is genuinely difficult and requires emergency evaluation including brain imaging and vascular studies. The diagnosis of migraine with brainstem aura should be established only after appropriate investigation has excluded structural and vascular causes.
Even in people with established diagnoses of migraine with brainstem aura, new episodes with features that differ from the established personal pattern warrant medical reassessment rather than automatic attribution to the known diagnosis.
Triptans have historically been considered relatively contraindicated in migraine with brainstem aura, based on theoretical concerns about their vasoconstrictive effects in the posterior circulation territory. More recent expert opinion is divided on whether the contraindication is clinically justified by the available evidence. Some headache specialists now use triptans in people with migraine with brainstem aura when the benefit-risk balance supports it, while others maintain caution. This is an active area of clinical debate and the decision should be made individually in consultation with a neurologist.
Ergotamine preparations are generally considered contraindicated in migraine with brainstem aura due to their vasoconstrictive properties.
Preventive treatment follows the general principles of migraine prevention. Beta blockers, calcium channel blockers particularly verapamil, tricyclic antidepressants, and CGRP-targeted therapies are all used in clinical practice for migraine with brainstem aura.
The diagnosis of migraine with brainstem aura is often a double-edged experience. The relief of understanding what is happening during these alarming episodes is significant. The ongoing reality of experiencing symptoms that resemble stroke, however briefly and however often, carries a psychological burden that is not fully addressed by the diagnosis alone.
People with this condition benefit from clear written guidance about which features of an attack can be managed at home versus which should trigger emergency evaluation. They also benefit from having their close contacts informed about the condition.
The condition is rare but it is manageable. The neurological symptoms of brainstem aura, however frightening in the moment, are reversible. With appropriate diagnosis, a clear treatment plan, and a clinician who understands the specific considerations involved, most people with migraine with brainstem aura can achieve meaningful reduction in episode frequency and a more informed, less frightened relationship with their condition.
International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018.
Bickerstaff ER. Basilar artery migraine. Lancet. 1961.
Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology. 2006.
Thomsen LL, Eriksen MK, Roemer SF, et al. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain. 2002.
American Migraine Foundation. Migraine with Brainstem Aura. americanmigrainefoundation.org
The most commonly missed migraine diagnosis — vertigo, imbalance, and dizziness as migraine symptoms, and how to distinguish it from Meniere's disease.
The neurological reality of migraine — why it is a brain disorder, what happens during an attack, and why the headache framing leads to underdiagnosis and undertreatment.
Twin study findings, genome-wide association research, familial hemiplegic migraine, and what the genetics of migraine means for diagnosis and family members.
How the trigeminovascular system generates migraine pain, the role of CGRP, central sensitization, and why early treatment matters.
Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.
Create Your Free AccountThe information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.